Latest News

In the last 8 hours
Pgi revives bariatric surgery programme amid rise of weight-loss injections The Times of India20:39 17-Apr-26
Yesterday
Is This the Biggest Game-Changer in Lilly's 150-Year History? The Motley Fool15:06 17-Apr-26
Annals of Internal Medicine presents breaking scientific news at ACP's Internal Medicine… PR Newswire (Press Release)14:39 17-Apr-26
New Study Finds Weight Loss Causes Significant Muscle Loss Newswise (Press Release)12:13 17-Apr-26
Common Obesity Medications Lead to Higher Muscle Loss Than Other Weight Loss Interventions, Review Finds Newswise (Press Release)12:04 17-Apr-26
Obesity biotech Kailera's record-breaking IPO pharmaphorum09:33 17-Apr-26
Social Media Captures GLP-1 Receptor Agonist Side Effects Not Seen in Clinical Trials MPR09:19 17-Apr-26
New diabetes drug helps lower blood sugar and body weight faster Knowridge Science Report06:41 17-Apr-26
Combination of prolonged water fasting and GLP-1 for refractory morbid obesity: Case report Nature.com05:46 17-Apr-26
Unlocking the Genetics of GLP-1 Medications: Why Your DNA Matters 23andMe Blog01:16 17-Apr-26
In the last 7 days
Worried About GLP-1 Shortages? Here's Exactly What To Ask Your Pharmacist Rock Hill Herald14:45 16-Apr-26
This could be why your weight-loss medication isn’t delivering results Fox News09:19 16-Apr-26
Record high scrips for Mounjaro for weight loss raise concern that urgent medical cases will get left out Korea JoongAng Daily05:24 16-Apr-26
Prediction: This 1 Thing Could Cement Eli Lilly's Leadership in the Billion-Dollar Weight Loss Drug Market The Motley Fool04:30 16-Apr-26
After 9,000 announced job cuts, Novo Nordisk taps OpenAI as it hires in China Drug Discovery & Development00:21 16-Apr-26
Doctor gets probation for selling weight-loss drugs from China to Mon Valley Hospital colleagues Pittsburgh Tribune-Review19:02 15-Apr-26
Considering Phentermine for Weight Loss? Who Should Take It Over a GLP-1 Rock Hill Herald14:15 15-Apr-26
Here’s how to spot misleading GLP-1 suppliers from online ads The Independent14:00 15-Apr-26
NVO Inks Deal With OpenAI for Speedy Drug Discovery Globally, Stock Up Zacks11:23 15-Apr-26
Some GLP-1 drugs are more effective for those with specific gene variants Science News Online11:04 15-Apr-26
FDA Clarifies Policies for Pharmacy Compounders of GLP-1 Products JD Supra09:16 15-Apr-26
GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price Business Wire (Press Release)09:10 15-Apr-26
Ads for GLP-1 drugs are flooding the internet – here’s how to know if it’s safe to buy them online The Conversation (US)08:48 15-Apr-26
PrecisionLife and Ovation ink collaboration agreement to launch GLP-1 stratification LDT and… PR Newswire (Press Release)08:09 15-Apr-26
Weight loss drugs and surgery show surprising hidden benefits Knowridge Science Report07:45 15-Apr-26
Novo, Lilly raise concerns over Korea's plan to classify GLP-1 obesity drugs as misuse-prone Korea Biomedical Review03:19 15-Apr-26
Everyone Wants This Unapproved Weight Loss Drug—And Some Have Found a Way to Get It SELF Magazine14:30 14-Apr-26
Indictment of Osteopathic Physician Signals Shift in Peptide Enforcement JD Supra13:21 14-Apr-26
Does NVO Face Rising Competitive Pressure on LLY's Foundayo Approval? Zacks11:25 14-Apr-26
Popular weight-loss medications linked to hidden side effects, study finds Fox News11:04 14-Apr-26
Five key weight loss jab side effects reported by 43 percent of patients The Mirror08:25 14-Apr-26
Thousands are sharing side effects of weight-loss drugs doctors may miss, study suggests BNN Bloomberg07:42 14-Apr-26
Switching drugs may improve health in people with type 2 diabetes Knowridge Science Report06:28 14-Apr-26
Study flags unreported GLP-1 side effects in analysis of social media posts BNN Bloomberg05:19 14-Apr-26
How to lose weight safely: Jabs, pills, or lifestyle Gulf News03:27 14-Apr-26
Making the most of QOF 2026/27 – key tips Management in Practice23:17 13-Apr-26
Scott Disick Shows Off Weight Loss While Promoting GLP-1 Medication The Kansas City Star17:42 13-Apr-26
Liver disease epidemic: Deadly disease now striking non-drinkers in record numbers - 1.8bn hit… MailOnline09:59 13-Apr-26
Profits among listed pharma companies surge to record $150 million Pakistan Today22:45 12-Apr-26
Cheaper generics capture 20% of weight-loss mkt The Times of India22:06 12-Apr-26
Retatrutide: Can this shot make you lose weight & live longer, too? The Economic Times14:58 12-Apr-26
Under trial, not approved: Inside the world of ‘Chinese peptides’ for weight loss in India The Times of India15:47 11-Apr-26
The hidden trade-off behind today’s most popular weight loss drugs Knowridge Science Report06:57 11-Apr-26
Weight-loss injections deliver in real life: 4 in 10 Indians shed 10% body weight The Times of India02:14 11-Apr-26
In the last month
Are GLP-1 Drugs Linked to Erectile Dysfunction? Medpage Today17:27 10-Apr-26
AI analyzes Reddit posts to find underreported GLP-1 side effects News-Medical.Net15:23 10-Apr-26
Apomeds Enters the UK Market With Its Digital Healthcare Platform PR Newswire (Press Release)13:57 10-Apr-26
Scientists uncover reason why some weight loss jab users struggle to shed pounds Daily Record11:10 10-Apr-26
AAD: Ixekizumab and Tirzepatide Boosts PsA Outcomes More Than Ixekizumab Monotherapy Dermatology Advisor10:50 10-Apr-26
GLP-1 and dual GLP-1 / GIP drugs help lose body fat while preserving lean mass News-Medical.Net10:07 10-Apr-26
Eli Lilly is losing market share as generic weight loss drugs flood the market in India Quartz09:12 10-Apr-26
MetaVia Doses the First Patient in Higher-Dose Phase 1 Study of DA-1726, Its GLP-1 and Glucagon … PR Newswire (Press Release)08:33 10-Apr-26
Genetics Tied to GLP-1 Weight Loss, Side Effects NewsMax08:20 10-Apr-26
Researchers pinpoint unreported weight loss jab side-effects that are currently affecting… MailOnline05:32 10-Apr-26
I'm A Celeb's Gemma Collins reveals 'life-changing' side effects after weight loss jabs The Mirror04:52 10-Apr-26
Medicine: Genetic differences may influence GLP1 treatment outcomes (Nature) Nature Asia00:38 10-Apr-26
Study finds nutritional risks in users of GLP-1 drugs News-Medical.Net23:26 9-Apr-26
Genetic variants may help explain who loses more weight and who gets side effects on GLP-1 drugs News-Medical.Net22:35 9-Apr-26
DOJ presses for its own search of Post reporter’s phone, laptops Boston Globe19:16 9-Apr-26
AI-Powered Drug Marketer Medvi Responds After Allegations About Fake Doctors and Patients Futurism18:26 9-Apr-26
'Knockoff' weight loss drugs can be life-threatening. CT’s attorney general wants the FDA to crack down News 12 Connecticut17:33 9-Apr-26
The Rise of GLP-1 Wedding Weight Loss Vogue14:37 9-Apr-26
How Will BALANCE Model Participation Impact Medicare Spending on Semaglutide? American College of Cardiology14:37 9-Apr-26
FDA Turns Up the Heat on GLP 1 Dupes Sold ​“For Research Use Only,” Finds Intended Use Suggests Otherwise JD Supra12:44 9-Apr-26
Ozempic Works Better for Some, New Study Finally Suggests Why The Tribune, California12:27 9-Apr-26
The real reason you're not getting skinny on weight-loss drugs like Ozempic and Wegovy... as… MailOnline11:54 9-Apr-26
Urban hype PharmaTimes10:04 9-Apr-26
GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound®… Business Wire (Press Release)07:33 9-Apr-26
Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakers The Economic Times07:06 9-Apr-26
Eli Lilly Faces Pressure In India As Cheaper GLP-1 Rivals Dent Mounjaro Sales Benzinga06:48 9-Apr-26
New NICE type 2 diabetes guidance among topics at free Pulse virtual event Read Now Pulse06:33 9-Apr-26
23andMe study explains variable results with obesity drugs pharmaphorum06:21 9-Apr-26
Eli Lilly’s Mounjaro loses ground to Novo Nordisk’s semaglutide, and the slew of cheaper generics The Hindu Business Line05:23 9-Apr-26
JW Pharmaceutical signs $81 mil. license-in deal with China's Gan & Lee for GLP-1 obesity drug Korea Biomedical Review23:56 8-Apr-26
Unlocking the Genetics of GLP-1 Medications Through Crowdsourced Science at 23andMe Behavioural and Social Sciences at Nature Research19:20 8-Apr-26
Vanda Pharmaceuticals Announces Initiation of The Thetis Study, a Clinical Trial of NEREUS™ for … PR Newswire (Press Release)16:46 8-Apr-26
Doctor reveals how 'rapid' weight loss jab can impact bones and how to prevent damage Daily Star15:30 8-Apr-26
Ixekizumab and Tirzepatide Improves Disease Activity in Psoriatic Arthritis Clinical Pain Advisor14:45 8-Apr-26
Which of These Healthcare Stocks Is More Likely to Be a Millionaire Maker? The Motley Fool14:26 8-Apr-26
Study finds genetic basis for GLP-1 weight loss efficacy and side effects News-Medical.Net13:23 8-Apr-26
Weight loss jabs ineffective? It could be in your genes, new study suggest MailOnline13:19 8-Apr-26
Genetic predictors of GLP1 receptor agonist weight loss and side effects Nature.com12:02 8-Apr-26
Why obesity drugs work better for some people: these genes hold clues Nature.com11:34 8-Apr-26
How well GLP-1 weight loss drugs work may depend on your genetics Scientific American11:26 8-Apr-26
Genes could predict weight-loss jab effectiveness – study Irish Examiner11:23 8-Apr-26
New light shed on who benefits most from weight-loss jabs BBC11:19 8-Apr-26
expert reaction to paper about genetic predictors of GLP1 receptor agonist weight loss and side effects Science Media Centre11:16 8-Apr-26
South Africa: What Breakthrough Weight Loss Meds Might Mean for People With HIV AllAfrica05:21 8-Apr-26
India’s generic semaglutide surge Chemistry World Magazine05:18 8-Apr-26
Weight loss jab warning as doctor reveals 'hidden' side effect that could impact your bones Daily Star04:08 8-Apr-26
Doctor issues warning to anyone taking weight loss jabs Cambridge News00:44 8-Apr-26
Doctor's warning for anyone using weight loss jabs The Mirror23:35 7-Apr-26
Consumers want weight-loss pills for cost and convenience Gulf Times18:08 7-Apr-26
Not Joking Around: FDA Offers Additional Clarification on Compounded GLP-1 Policy in April Fool’s Day Announcement National Law Review16:03 7-Apr-26
FDA Clarifies Policies on Compounded GLP-1s, Warns Companies JD Supra12:35 7-Apr-26
How Thermo Fisher’s Glacios 3 aims to broaden access to cryo-EM Drug Discovery & Development19:56 6-Apr-26
Zepbound vs. Wegovy: Which Weight Loss Medication Is Better Right Now? Rock Hill Herald14:31 6-Apr-26
The Dangerous Allure of Compounded GLP-1 Drugs Psychology Today13:49 6-Apr-26
AAD: Ixekizumab + Tirzepatide Boosts Psoriatic Arthritis Outcomes More Than Ixekizumab Monotherapy HealthDay11:47 6-Apr-26
Tirzepatide Associated With Lower Mortality Risk Than Dulaglutide in T2D Endocrinology Advisor09:49 6-Apr-26
FDA reversal on peptides could open the market to unsafe drugs Daily Kos11:01 5-Apr-26
Dulaglutide or Tirzepatide? Worldwide Biopharma Changes Medpage Today14:07 4-Apr-26
Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug Fight The Motley Fool13:56 4-Apr-26
Doctors Warn This 'Cheaper' Ozempic Alternative May Come With Risks The Tribune, California11:06 4-Apr-26
New diabetes treatment may help patients improve well-being Knowridge Science Report06:26 4-Apr-26
Rfk accused of spinning peptide safety Salon.com06:10 4-Apr-26
Rfk Jr. May Reverse a Peptide Ban He Calls “Illegal.” Former FDA Officials Say He… ProPublica05:04 3-Apr-26
Sleep apnea raises risk of cardiovascular events and death News-Medical.Net21:09 2-Apr-26
How Eli Lilly’s new GLP‑1 pill stacks up against Wegovy and other weight‑loss drugs Scientific American16:35 2-Apr-26
Ro Launches Eli Lilly's Kwikpen®, Offering Patients A More Convenient Way To Take Zepbound® PR Newswire (Press Release)13:04 2-Apr-26
New weight-loss pill hits the market, promising 'greater flexibility' Fox News12:33 2-Apr-26
A Brand New Weight Loss Pill Just Hit the Market. Here’s How It’s Different. Women's Health12:28 2-Apr-26
LLY Stock Up on GLP-1 Pill Approval: Can it Outpace NVO's Wegovy Pill? Zacks10:59 2-Apr-26
ACC 2026: Meta-analysis supports CagriSema as superior first-line therapy in obesity Pharmaceutical Technology08:53 2-Apr-26
Prediction: This Will Be Eli Lilly's Next Billion-Dollar Growth Driver. (Hint: It's Not Weight Loss Drugs.) The Motley Fool04:48 2-Apr-26

      
            
      
    view more headlines
   
      
      
      
17 Apr 20:39
   

About our Tirzepatide news

Latest news on Tirzepatide, a drug that is being developed as a potential treatment for obesity and type 2 diabetes. It is a synthetic hormone that is designed to mimic the effects of natural hormones called incretins, which help to lower blood sugar and reduce appetite. Tirzepatide has shown promise in clinical trials, producing significant weight loss in people with obesity or type 2 diabetes. It is administered as a once-weekly injection, and it is believed to work by increasing the production of a hormone called GLP-1, which helps to regulate appetite and insulin production. Tirzepatide is currently in late-stage clinical trials, and it is expected to be considered for regulatory approval in the coming years.

Tirzepatide

Latest News

About our Tirzepatide news

Health Top Stories

Lifestyle Top Stories